FDAFDA · Food and drugs·Recall number D-1106-2023
NAD+ 200mg/ml, 10ml vials, Tailor Made Compounding.
Published August 30, 2023 · Recall initiated: August 15, 2023
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility
What to do
Voluntary: Firm initiated · Letter
Recall details
- Manufacturer
- TMC Acquisitions LLC dba Tailor Made Compounding
- Distributor
- Nationwide within the USA
- Lot
- Lot#: 07192307A2, BUD: 11/18/2023
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.